MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synuclenopathies

    I. Martinez-Valbuena, R. Valenti-Azcarate, I. Amat-Villegas, M.M. Carmona-Abellan, I. Marcilla-Garcia, L. Alonso-Herrero, G. Marti-Andres, T. Tuñon-Alvarez, M.R. Luquin-Piudo (Pamplona, Spain)

    Objective: We have investigated whether deposits of phosphorylated α-synuclein might be present in pancreatic tissue of subjects with synucleinopathies. Background: Parkinson’s disease patients experience a…
  • 2018 International Congress

    Long-term efficacy and safety of incobotulinumtoxinA treatment for sialorrhea in Parkinson’s disease and other neurologic conditions

    F. Pagan, W. Jost, A. Friedman, O. Michel, C. Oehlwein, J. Slawek, A. Bogucki, S. Ochudlo, M. Banach, B. Flatau-Baqué, J. Csikós, A. Blitzer (Washington, DC, USA)

    Objective: SIAXI (NCT02091739), a pivotal double-blind, randomised, placebo-controlled study with a 48-week extension period (EP), assessed the efficacy and safety of incobotulinumtoxinA 75 U or…
  • 2018 International Congress

    Visual deficits of self-motion perception in Parkinson’s disease

    S. Yakubovich, O. Halperin, S. Hassin, S. Israeli-Korn, A. Zaidel (Ramat Gan, Israel)

    Objective: To investigate unisensory and multisensory self-motion perception mediated by the visual and vestibular systems in PD. Background: Parkinson's disease (PD) is classically characterized by…
  • 2018 International Congress

    Single-centre open label exploratory phase IIb pilot study of exogenous oral Melatonin for the treatment of Nocturia in adults with Parkinson’s disease

    A. Batla, U. Uchiyama, S. Simeoni, C. Melbourne, M. Baldwin, L. DeMin, G. Gonzales, C. Haslam, M. Pakzad, S. Islam, S. Eriksson, K. Bhatia, J. Panicker (London, United Kingdom)

    Objective: To evaluate the effect of melatonin on nocturia. Background: Nocturia is one of the commonest non motor symptoms in Parkinsons’ disease (PD), and has…
  • 2018 International Congress

    Impact of injection guidance techniques on the efficacy and safety of incobotulinumtoxinA for sialorrhea

    F. Pagan, W. Jost, A. Friedman, O. Michel, C. Oehlwein, J. Slawek, A. Bogucki, S. Ochudlo, M. Banach, B. Flatau-Baqué, J. Csikós, A. Blitzer (Washington, DC, USA)

    Objective: SIAXI (NCT02091739), a pivotal double-blind, randomised, placebo-controlled study with an extension period (EP), assessed the efficacy and safety of incobotulinumtoxinA 75 or 100 U…
  • 2018 International Congress

    Vowel characteristics associated with Parkinson’s disease in Cantonese

    N. Leung, E. Tong, M. Ng (Pokfulam, Hong Kong)

    Objective: Dopaminergic treatment has been reported to help motor problem associated with Parkinson's disease (PD), but not speech motor. The current study examined vowel articulation…
  • 2018 International Congress

    Non motor symptoms in parkinsonism: A cross sectional study

    V. Kataria, V. Goyal (New Delhi, India)

    Objective: Non motor symptoms (NMS) in idiopathic Parkinson’s disease (PD) are well studied and has an effect on quality of life in PD. NMS in…
  • 2018 International Congress

    Restless legs syndrome in Parkinson’s disease patients: a comparative study on prevalence, clinical features, motor and non-motor symptoms

    S.Y. You, J.S. Lee, S.M. Jeon, Y.W. Cho (Daegu, Republic of Korea)

    Objective: We investigate the prevalence of restless legs syndrome in Parkinson’s disease patients and to identify associated clinical features, motor and non-motor symptoms. Background: Restless…
  • 2018 International Congress

    Nursing diagnoses, outcomes and ICNP® interventions related to urinary dysfunction in Parkinson’s disease

    M. Tosin, B. Oliveira (Santos-SP, Brazil)

    Objective: To describe the nursing diagnoses, outcomes and interventions related to urinary dysfunction in Parkinson disease. Background: The complexity of motor and nonmotor symptoms in…
  • 2018 International Congress

    Gut microbiota geography in Parkinson’s disease in the world

    M. Hirayama, T. Maeda, T. Minato, M. Itoh, J. Takeda, T. Hamaguchi, M. Katsuno, K. Ohno (Nagoya, Japan)

    Objective: The 16 rRNA analysis and the shotgun metagenome analysis in our cohort were compared with 5 previous reports by others. Background: In PD patients,…
  • « Previous Page
  • 1
  • …
  • 1172
  • 1173
  • 1174
  • 1175
  • 1176
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • #24752 (not found)
    • Effect of Aspartame on Parkinson’s Disease Progression and Severity
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley